Moderna produces Covid-19 shot targeting variant discovered in SA The US biotech is preparing for a clinical trial to gauge the effectiveness of the vaccine on 501.V2 strain 25 February 2021 - 19:55 By Hannah Kuchler
Moderna has become the first vaccine maker to produce a Covid-19 shot targeted at the virus variant discovered in SA. It will ship the doses to the US National Institutes of Health (NIH) for a clinical trial.
The Boston-based biotech is taking a three-pronged strategy to address concerns that its vaccine, with several others, is less effective against the 501.V2 strain. ..
This article is reserved for Sunday Times subscribers.
Covid-19 news: One dose of Pfizer vaccine greatly reduced transmission newscientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newscientist.com Daily Mail and Mail on Sunday newspapers.
really behind her mask is a fierce female who loves bubbly a little too much, takes life a little seriously, but knows the importance of working hard and balancing that out with some good fun! By Jessica Tennant
Takealot competitor Everyshop officially launchesAfter a month of public testing in March, the new South African online marketplace Everyshop has officially launched, offering delivery across South Africa.
Elevator partners with IMA, rebrands to SA chapterElevator Agency is partnering with the global Intermarketing Agency (IMA) and will rebrand, becoming the South African chapter of IMA, effective April 2021.
Pfizer earlier this month forecast $15 billion in its share of sales from the COVID-19 vaccine it developed jointly with partner BioNTech., , Moderna, COVID-19 Vaccine, sales, pfizer, shares